Search

everythinglearnresearchcommunity

for

Search:↓

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Biological factors are crucial for developing new hair restoration treatments.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

The system can have a stable solution under certain conditions, helping understand hair loss in Alopecia Areata.

Scalp cooling can effectively reduce hair loss during chemotherapy, with modern methods improving comfort and accessibility.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Chemotherapy and radiotherapy do not significantly affect obstructive sleep apnea development.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Females had more chemotherapy side effects than males, with many being preventable.

Bimatoprost effectively improves eyelashes in chemotherapy patients.

Addressing hair loss's psychological effects with mental health support is crucial for cancer survivors.

More effective methods are needed to prevent hair loss from chemotherapy.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Facebook groups play a crucial role in supporting and guiding patients on scalp cooling and hair loss during chemotherapy.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Chemotherapy in children often causes hair loss, nausea, vomiting, and mood swings.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.